Prevention and treatment of androgendeprivation induced osteoporosis

Details for Australian Patent Application No. 2002356928 (hide)

Owner GTX Inc.

Inventors Steiner, Mitchell S

Agent Griffith Hack

Pub. Number AU-B-2002356928

PCT Number PCT/US02/36136

PCT Pub. Number WO2003/047504

Priority 60/333,734 29.11.01 US

Filing date 27 November 2002

Wipo publication date 17 June 2003

Acceptance publication date 17 April 2008

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/333,734 29.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002356928

17 April 2008 Application Accepted

  Published as AU-B-2002356928

14 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002356929-CATALYTIC CARBONYLATION OF THREE AND FOUR MEMBERED HETEROCYCLES

2002356927-PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS